BITHYREX Trademark

Trademark Overview

On Friday, November 22, 2019, a trademark application was filed for BITHYREX with the United States Patent and Trademark Office. The USPTO has given the BITHYREX trademark a serial number of 88702648. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 2, 2023. This trademark is owned by Spectrix Therapeutics, LLC. The BITHYREX trademark is filed in the Pharmaceutical Products category with the following description:

Extended release thyroid medicine
bithyrex

General Information

Serial Number88702648
Word MarkBITHYREX
Filing DateFriday, November 22, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2020

Trademark Statements

Goods and ServicesExtended release thyroid medicine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpectrix Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSouthlake, TX 76092
Party NameSpectrix Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouthlake, TX 76092

Trademark Events

Event DateEvent Description
Tuesday, January 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 2, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU EXTENSION 4 GRANTED
Tuesday, April 26, 2022SOU EXTENSION 4 FILED
Tuesday, April 26, 2022TEAS EXTENSION RECEIVED
Thursday, November 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 2, 2021SOU EXTENSION 3 GRANTED
Tuesday, November 2, 2021SOU EXTENSION 3 FILED
Tuesday, November 2, 2021TEAS EXTENSION RECEIVED
Wednesday, June 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 12, 2021SOU EXTENSION 2 GRANTED
Monday, April 12, 2021SOU EXTENSION 2 FILED
Monday, April 12, 2021TEAS EXTENSION RECEIVED
Thursday, November 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 10, 2020SOU EXTENSION 1 GRANTED
Tuesday, November 10, 2020SOU EXTENSION 1 FILED
Tuesday, November 10, 2020TEAS EXTENSION RECEIVED
Tuesday, June 2, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 27, 2020ASSIGNED TO EXAMINER
Saturday, November 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 26, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

bithyrex medicine thyroid release extended